FTC sues significant pharmacy advantage professionals around insulin prices The agency introduced action towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of daily life-saving insulin medications. Never miss tomorrow's healthcare market news Permit Healthcare Dive's totally free newslet... https://kethek.com/